1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight 19 JANUARY 2015

Drug Delivery Insight 19 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Compliance Burden Key Driver For Drug-Delivery Implants
Industry Trend Analysis - Nucynta Deal Will More Than Double Depomed's Annual Net Product Sales
Industry Brief - Vectura/Janssen Sign Deal To Develop Anti-Inflammatory Therapy
Industry Brief - Hospira Unveils Progress On Global Device Strategy
Industry Brief - Seattle Genetics/BMS Enter Clinical Trial Collaboration For Adcetris/Opdivo
Industry Brief - BioLight Invests In Newly-Formed Ophthalmic Company
Industry Brief - Vect-Horus/Sanofi Enter Collaboration For Neurodegenerative Diseases
Industry Brief - FDA Clears t:flex Insulin Pump With Expanded Reservoir
Industry Brief - FDA Approves AbbVie's Duopa For Motor Fluctuations In Advanced PD Patients
Industry Brief - La Fenice Insulin Pump Gains Re-Registration Approval In China
Industry Brief - Flowonix Gains Supplemental PMA For Next-Generation Intrathecal Infusion Device
Industry Trend Analysis - Medical Devices Appetite Growing For 3D Printing
Industry Trend Analysis - NSAID Market Set To Welcome Encapsulated Equivalents
Industry Brief - Sacituzumab Govitecan Gains FDA Fast Track Designation For TNBC
Industry Brief - LEO Submits NDA For Calcipotriene+Betamethasone Aerosol Foam In Plaque Psoriasis
Industry Brief - Enrolment Begins In Tyrx Absorbable Antibacterial Envelope Trial For CIEDs Infections
Industry Brief - Novartis Reports Positive Results From Phase III COPD Studies
Industry Brief - Neos Submits NDA For Methylphenidate XR-ODT For ADHD
Industry Brief - First Of Three Sativex Phase III Cancer Pain Trials Misses Primary Endpoint
Industry Brief - Photocure Concludes End Of Phase II Status For Cevira In US
Industry Brief - Oramed Granted Patent In Israel Covering Exenatide
Industry Brief - Actavis Challenges US Abstral Patents

Table Of Contents

Drug Delivery Insight 19 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.